These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 1328660

  • 1. The neurotoxin 1-methyl-4-phenylpyridinium: a selective cytostatic agent in small-cell lung cancer cell lines with neuroendocrine properties.
    Marini AM, Fridman R, Kanemoto T, Martin GR, Guo Y, Passaniti A.
    J Natl Cancer Inst; 1992 Oct 21; 84(20):1582-7. PubMed ID: 1328660
    [Abstract] [Full Text] [Related]

  • 2. Reconstituted basement membrane (matrigel) and laminin can enhance the tumorigenicity and the drug resistance of small cell lung cancer cell lines.
    Fridman R, Giaccone G, Kanemoto T, Martin GR, Gazdar AF, Mulshine JL.
    Proc Natl Acad Sci U S A; 1990 Sep 21; 87(17):6698-702. PubMed ID: 2168554
    [Abstract] [Full Text] [Related]

  • 3. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.
    Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M.
    J Natl Cancer Inst; 1995 Nov 15; 87(22):1674-80. PubMed ID: 7473815
    [Abstract] [Full Text] [Related]

  • 4. Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification.
    Kalemkerian GP, Ou X, Adil MR, Rosati R, Khoulani MM, Madan SK, Pettit GR.
    Cancer Chemother Pharmacol; 1999 Nov 15; 43(6):507-15. PubMed ID: 10321512
    [Abstract] [Full Text] [Related]

  • 5. Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571.
    Wang WL, Healy ME, Sattler M, Verma S, Lin J, Maulik G, Stiles CD, Griffin JD, Johnson BE, Salgia R.
    Oncogene; 2000 Jul 20; 19(31):3521-8. PubMed ID: 10918610
    [Abstract] [Full Text] [Related]

  • 6. Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
    Chan DC, Gera L, Stewart JM, Helfrich B, Zhao TL, Feng WY, Chan KK, Covey JM, Bunn PA.
    Clin Cancer Res; 2002 May 20; 8(5):1280-7. PubMed ID: 12006549
    [Abstract] [Full Text] [Related]

  • 7. Reduced DNA synthesis and cell viability in small cell lung carcinoma by treatment with cyclic AMP phosphodiesterase inhibitors.
    Shafer SH, Phelps SH, Williams CL.
    Biochem Pharmacol; 1998 Nov 01; 56(9):1229-36. PubMed ID: 9802335
    [Abstract] [Full Text] [Related]

  • 8. Correlation of expression of bombesin-like peptides and receptors with growth inhibition by an anti-bombesin antibody in small-cell lung cancer cell lines.
    Yang HK, Scott FM, Trepel JB, Battey JF, Johnson BE, Kelley MJ.
    Lung Cancer; 1998 Sep 01; 21(3):165-75. PubMed ID: 9857994
    [Abstract] [Full Text] [Related]

  • 9. Antitumoral activity of bombesin analogues on small cell lung cancer xenografts: relationship with bombesin receptor expression.
    Thomas F, Arvelo F, Antoine E, Jacrot M, Poupon MF.
    Cancer Res; 1992 Sep 15; 52(18):4872-7. PubMed ID: 1325285
    [Abstract] [Full Text] [Related]

  • 10. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
    Ali MA, Rosati R, Pettit GR, Kalemkerian GP.
    Anticancer Res; 1998 Sep 15; 18(2A):1021-6. PubMed ID: 9615758
    [Abstract] [Full Text] [Related]

  • 11. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
    Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R.
    Cancer Res; 2003 Oct 01; 63(19):6272-81. PubMed ID: 14559814
    [Abstract] [Full Text] [Related]

  • 12. Transferrin dependence of Ga (NO3)3 inhibition of growth in human-derived small cell lung cancer cells.
    Weiner RE, Avis I, Neumann RD, Mulshine JL.
    J Cell Biochem Suppl; 1996 Oct 01; 24():276-87. PubMed ID: 8806110
    [Abstract] [Full Text] [Related]

  • 13. Determinants of the sensitivity of human small-cell lung cancer cell lines to methotrexate.
    Curt GA, Jolivet J, Carney DN, Bailey BD, Drake JC, Clendeninn NJ, Chabner BA.
    J Clin Invest; 1985 Oct 01; 76(4):1323-9. PubMed ID: 2414316
    [Abstract] [Full Text] [Related]

  • 14. Induction of phenotypic changes in SCLC cell lines in vitro by hexamethylene bisacetamide, sodium butyrate, and cyclic AMP.
    Khan MZ, Freshney RI, McNicol AM, Murray AM.
    Ann Oncol; 1993 Jun 01; 4(6):499-507. PubMed ID: 8394737
    [Abstract] [Full Text] [Related]

  • 15. The aromatic-L-amino acid decarboxylase inhibitor carbidopa is selectively cytotoxic to human pulmonary carcinoid and small cell lung carcinoma cells.
    Gilbert JA, Frederick LM, Ames MM.
    Clin Cancer Res; 2000 Nov 01; 6(11):4365-72. PubMed ID: 11106255
    [Abstract] [Full Text] [Related]

  • 16. Corticotropin-releasing factor receptors in human small cell lung carcinoma cells: radioligand binding, second messenger, and northern blot analysis data.
    Dieterich KD, Grigoriadis DE, De Souza EB.
    Endocrinology; 1994 Oct 01; 135(4):1551-8. PubMed ID: 7925116
    [Abstract] [Full Text] [Related]

  • 17. Small cell lung carcinoma exhibits greater phospholipase C-beta1 expression and edelfosine resistance compared with non-small cell lung carcinoma.
    Strassheim D, Shafer SH, Phelps SH, Williams CL.
    Cancer Res; 2000 May 15; 60(10):2730-6. PubMed ID: 10825148
    [Abstract] [Full Text] [Related]

  • 18. The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies.
    Varker KA, Phelps SH, King MM, Williams CL.
    Int J Oncol; 2003 Mar 15; 22(3):671-81. PubMed ID: 12579323
    [Abstract] [Full Text] [Related]

  • 19. Specific sensitivity of small cell lung cancer cell lines to the snake venom toxin taipoxin.
    Poulsen TT, Pedersen N, Perin MS, Hansen CK, Poulsen HS.
    Lung Cancer; 2005 Dec 15; 50(3):329-37. PubMed ID: 16115696
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of differentiation markers can accompany laminin-induced attachment of small cell lung cancer cells.
    Giaccone G, Broers J, Jensen S, Fridman RI, Linnoila R, Gazdar AF.
    Br J Cancer; 1992 Sep 15; 66(3):488-95. PubMed ID: 1325826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.